Machelle McDowell, NP
Payments from drug & device makers
Across 724 payments — averaging $142.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$46K
- Johnson & Johnson$41K
- Janssen Scientific Affairs, LLC$8K
- Takeda Pharmaceuticals U.S.A., Inc.$2K
- Merck$1K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
- plus $3K from 26 others
Across 6 payments — averaging $198.32 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$1K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 330 | $45,842 |
| Johnson & Johnson | 86 | $40,980 |
| Janssen Scientific Affairs, LLC | 23 | $8,462 |
| Takeda Pharmaceuticals U.S.A., Inc. | 72 | $1,770 |
| Merck | 11 | $1,308 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 83 | $1,197 |
| Sanofi | 24 | $629 |
| Ardelyx, Inc. | 14 | $391 |
| Gilead | 5 | $319 |
| Pfizer | 23 | $307 |
| Intercept Pharmaceuticals, Inc. | 4 | $233 |
| E.r. Squibb & Sons, L.L.C. | 2 | $191 |
| Aimmune Therapeutics, Inc. | 5 | $187 |
| QOL Medical, LLC | 4 | $157 |
| Evoke Pharma, Inc. | 2 | $148 |
| Phathom Pharmaceuticals, Inc. | 1 | $125 |
| Eisai Inc. | 1 | $124 |
| Lilly USA, LLC | 7 | $122 |
| Regeneron Healthcare Solutions, Inc. | 1 | $86 |
| Bristol Myers Squibb | 5 | $75 |
| Janssen Research & Development, LLC | 1 | $54 |
| Nestle Healthcare Nutrition Inc. | 3 | $52 |
| Amgen | 2 | $48 |
| Novo Nordisk | 1 | $46 |
| Organon | 4 | $35 |
| Ipsen Biopharmaceuticals, Inc | 2 | $32 |
| Braintree Laboratories, Inc. | 2 | $30 |
| Celltrion USA Inc. | 2 | $28 |
| AstraZeneca | 1 | $21 |
| Fresenius Kabi USA, LLC | 1 | $18 |
| Boston Scientific | 1 | $16 |
| Mirum Pharmaceuticals, Inc. | 1 | $14 |
How this compares
$103,048 in reported general payments places this provider in the 95th percentile of 15,456 family providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other family in Tyler
- Jonathan KingTyler$97K
- Kirsten StuberTyler$79K
- Lashonda CraneHouston$3.4M
- David WeirDallas$959K
- Luba YammineHouston$479K
- Robin BeachHouston$428K
- Nirupama JeromeAustin$418K
- April LopezMcAllen$417K
- Linda MercadoHouston$211K
- Sarah AguilarHouston$199K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.